Issues & Trends

NUVOTEC Co., Ltd. Reports First-Half Revenue of 21.8 Billion… Clear Trend Toward Improved Profitability

Operating Profit Soars 291.0%

Kwon Oh Seok
2026-08-14 15:08:35
[Edaily Reporter Kwon Oh Seok ] NUVOTEC Co., Ltd(060260), a company specializing in environmental infrastructure, achieved solid growth by significantly improving its profitability in the first half of this year despite adverse factors such as rising raw material prices and supply chain disruptions.
(Photo: NUVOTEC Co., Ltd)

NUVOTEC Co., Ltd announced on the 14th through its semi-annual report that it recorded revenue of 21.8 billion won and operating profit of 500 million won on a non-consolidated basis for the first half of 2026. These figures represent increases of 1.3% and 9.3%, respectively, compared to the same period last year.
In particular, operating profit from continuing operations—excluding the impact of discontinued operations, which was a one-time factor—reached 700 million won, surging by a staggering 291.0% compared to the same period last year. With the scale of profit from core operations expanding significantly, analysts note that the trend toward improved profitability through structural reforms has become clearly evident.
The company explained that these results are particularly significant as they were achieved amid adverse conditions, including rising international oil prices due to prolonged geopolitical risks (conflicts in Russia, Ukraine, and the Middle East), price volatility in key raw materials such as PVC resin, and ongoing global supply chain disruptions. NUVOTEC Co., Ltd has successfully managed cost pressures by securing raw material inventories through proactive monitoring, diversifying its suppliers, and streamlining production processes to focus on high-value-added products.
By business segment, the flagship Water Supply and Sewerage Division led the earnings growth, recording production revenue of 16.4 billion won—a 17.6% increase compared to the same period last year—based on its solid position in both the government-contracted and private-sector markets. The De-icing Agent Division also maintained stable sales by actively targeting the preemptive stockpiling demand from local governments seeking to prepare for geopolitical instability, despite unfavorable conditions such as reduced snowfall.
In line with this improved performance, NUVOTEC Co., Ltd is also implementing proactive policies to enhance shareholder value. Following the cancellation of 169,653 treasury shares in April, the company entered into a trust agreement in June to repurchase treasury shares worth 1.4 billion won. Through these measures, the company has completed the repurchase of a total of 985,751 shares (approximately 7.39% of the total issued shares) to date, accelerating efforts to stabilize the stock price and return value to shareholders.
Hwang Hee-seon, CEO of NUVOTEC Co., Ltd, emphasized, “The first half of this year was a period in which we took the profitability of our core business to the next level through proactive risk management and process efficiency improvements, even amid ongoing volatility in raw material prices and the supply chain.” He added, “Building on our stabilized business foundation, we will gradually materialize new growth drivers to lay the groundwork for sustained growth.”

Economy

Corporation

IT·Science

Economy

[Market In] After Buying 1 Trillion Won a Day… Why Did SK hynix Halt Its Bond Investments?

Attention is focused on the reasons behind SK hynix(000660)’s sudden suspension of corporate bond investments. Although the company emerged as a “big player” by aggressively purchasing bonds—starting …
2026-08-15 01:45:05

Corporation

Lotte’s Shin Dong-bin Tops the List of Retail Industry Leaders in Compensation for the First Half of This Year

Shin Dong-bin, Chairman of Lotte Group, received the highest compensation among the heads of major retail companies in the first half of this year. Shin Dong-bin, Chairman of Lotte Group. (Photo co…
2026-08-14 20:18:41

IT·Science

JWPHARMACEUTICAL Files IND Application for Phase 3 Domestic Clinical Trials of 'Once-Every-Two-Weeks' Weight-Loss Drug

JWPHARMACEUTICAL CI (Photo courtesy of JWPHARMACEUTICAL) JWPHARMACEUTICAL(001060)announced on the 14th that it has submitted an Investigational New Drug (IND) application to the Ministry of Food a…
2026-08-14 22:35:03